CD274 and neoplasm: Thus, reliable tools for a non-invasive prediction of the intracranial PD-L1 expression and further development of radiomics signatures for characterization of the local immune features and quantification of PD-L1 expressing tumor-infiltrating lymphocytes are of high clinical relevance and may be beneficial for personalized precision treatment.